Compare Charles River Laboratories Intl. Inc (CRL) vs Dow Inc (DOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Dow Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Dow Inc trades at $28.42 (market cap $20.65B). The key difference: Dow Inc is the larger of the two by market cap, and Dow Inc pays a 4.9% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Dow Inc for 82 Days on average.
| CRL | DOW | |
|---|---|---|
Market Cap | $14.23B | $20.65B |
Volume | 1,176,885 | 14,126,943 |
Sector | Health | Basic Materials |
52-Week High | $310.77 | $41.87 |
52-Week Low | $149.93 | $20.65 |
Typical Hold Time | 33 Days | 82 Days |
Enterprise Value | $17.06B | $36.34B |
Dividend Yield | — | 4.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298.00, down 0.77% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, though it reported a net loss of -$144.34M for 2025. Analyst consensus is strongly positive with a $305.50 price target, and recent news highlights a strategic growth plan targeting 5%-7% revenue growth by 2030.
The stock's outlook is supported by strong analyst buy ratings and a clear growth strategy, but faces risks from negative profitability metrics and high valuation multiples. Investment opportunity hinges on successful execution of margin expansion and cost savings initiatives, while key risks include persistent net losses and competitive pressures in the healthcare services sector.
DOW trades at $28.59, up 2.95% today, with a bullish technical signal despite mixed indicators. The stock shows deteriorating fundamentals with negative net income margin (-3.13%) and ROE (-7.86%) in 2025, though recent quarters have beaten EPS expectations. Cash flow trends show operational challenges with declining operating cash flow from $7.5B in 2022 to $1.0B in 2025, offset by increased financing activities.
The outlook remains cautious with analyst consensus at 'Hold' (55.55%) and $34.22 price target offering 20% upside. Key risks include persistent margin pressures, high debt levels (debt-to-asset ratio 29.87% in 2025), and cyclical chemical industry exposure. The dividend yield provides some support, but fundamental improvement is needed for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Dow Inc
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →
